Benzinga•2026-04-21
S&P 500 Eases On Iran Ceasefire Jitters, Crude Soars To $90: Stock Market TodayINSP — Inspire Medical Systems Inc
NYSE · Health Care · Health Care
$54.20-53.08%Market cap1.57B
- Latest Close
- $54.2
- 30-Day Move
- -53.1%
- Market Cap
- $1.6B
- Shares Outstanding
- 28,590,000
- P/E Ratio
- 10.81
- P/B Ratio
- 3.43
Analyst consensus: Buy · 25 analysts
NYSE:INSPHealth Care / Health CareDelayed public snapshot
Inspire Medical Systems Inc
A read-only Alphactor snapshot forInspire Medical Systems Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-23
Topline snapshot
Latest Close
$54.2
30-Day Move
-53.1%
Market Cap
$1.6B
Shares Outstanding
28,590,000
P/E Ratio
10.81
P/B Ratio
3.43
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$54.20
-53.1%last 90 delayed daily bars
Market cap$1.6B
90D High
$121.45
90D Low
$48.30
Avg Volume
1,288,174
What stands out
Gross margin is running at 85.4%, which gives a quick read on operating quality before you open the full model.
Net margin is 15.9%, useful for comparing INSP against peers in Health Care.
INSP is down 53.1% over the last 30 trading days shown on this page.
Latest operating income is $46M, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Composite Fair Value
$138.91
Rule of 40
22.2%
Dark Pool Short %
79.1%
Search Interest
60
Fundamentals snapshot
Latest Close
$54.2
30-Day Move
-53.1%
Market Cap
$1.6B
Shares Outstanding
28,590,000
P/E Ratio
10.81
P/B Ratio
3.43
ROE
18.6%
ROA
16.0%
Gross Margin
85.4%
Operating Margin
5.2%
Net Margin
15.9%
Debt / Equity
0
Current Ratio
6.08
Latest Revenue
$269M
Financial statement snapshot
Revenue
$269M
Gross Profit
$233M
Operating Income
$46M
Net Income
$136M
Gross Margin
8539.0%
Net Margin
1595.0%
Current Ratio
6.08
Debt / Equity
0.00
Valuation snapshot
Fair Value
$138.91
Upside / Downside
+156.3%
Signal
Undervalued
Implied Growth
6.8%
DCF
$115.79
EV/Rev
$162.03
Growth Assumption
30.8%
Discount Rate
9.6%
Terminal Growth
2.0%
Base FCF
$78M
Valuation spread
Current Price
$54.20
Composite Fair Value
$138.91
DCF
$115.79
EV/Rev
$162.03
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Low growth priced in
Quality snapshot
Altman Z
9.09
Safe
Piotroski
6
Moderate (4-6)
Cash Conversion
0.80x
Rule of 40
22.2%
Concerning
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $408M | $-48M | $-45M | $2M |
| 2023-12-31 | $625M | $-40M | $-21M | $1M |
| 2024-12-31 | $803M | $36M | $54M | $91M |
| 2025-12-31 | $912M | $51M | $145M | $78M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
After signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Insider activity snapshot
Buy Value
$0
Sell Value
$2M
Buys
0
Sells
8
Buy Value
$0
Sell Value
$2M
Buy/Sell Ratio
0.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
Recent insider transactions
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-15 | Melenikiotou Georgia | A | 307 | $52.07 |
| 2026-04-15 | Tansey Casey M | A | 308 | $52.07 |
| 2026-04-15 | Broader Shelley G | A | 342 | $52.07 |
| 2026-04-15 | Ellis Gary Lee | A | 518 | $52.07 |
| 2026-02-20 | Herbert Timothy P. | A | 62,153 | $0.00 |
| 2026-02-20 | Herbert Timothy P. | F | 4,010 | $59.53 |
| 2026-02-20 | Herbert Timothy P. | A | 9,005 | $0.00 |
| 2026-02-20 | Kelly Jason P | A | 15,958 | $0.00 |
ETF holders snapshot
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 1,606,067 | 0.06% | 2026-02-28 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1,094,019 | 0.04% | 2026-01-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 899,585 | 0.03% | 2025-12-31 |
| Vanguard Explorer Fund | 761,650 | 0.03% | 2026-01-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 658,797 | 0.02% | 2025-12-31 |
| VANGUARD WORLD FUND-Vanguard U.S. Growth Fund | 577,835 | 0.02% | 2025-11-30 |
| Artisan Partners Funds Inc.-Artisan International Small-Mid Fund | 481,990 | 0.02% | 2025-12-31 |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Growth Fund | 442,900 | 0.02% | 2025-12-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Institutional holders snapshot
Qube Research & Technologies
Filed 2026-02-17
--
--
Two Sigma Advisers
Filed 2025-08-14
--
--
Vanguard Group
Filed 2025-05-09
$514M
-1.4%
BlackRock
Filed 2024-05-10
$406M
--
Citadel Advisors
Filed 2025-11-14
$130M
--
D.E. Shaw
Filed 2026-02-17
$112M
+237.8%
Geode Capital Management
Filed 2025-08-08
$67M
+0.3%
Man Group
Filed 2025-08-14
$49M
--
Search interest snapshot
Latest Interest
60
Peak Interest
88
After signup
The full trends view adds more narrative depth
Go deeper into related queries, regional interest, and the broader narrative behind retail attention.
Track how that search interest lines up with price moves, alerts, and saved ideas after signup.
Dark-pool activity snapshot
Analyst consensus?
Rating(?)
3.6
Consensus
BuyTarget Mean(?)
—
Target High(?)
—
Target Low(?)
—
Analysts
25
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Healthcare Investing: Pharma, Biotech, and the FDA Calendar
A framework for navigating healthcare stocks across pharma, biotech, and medical devices, with emphasis on regulatory catalysts and pipeline valuation.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.